Screener
Aptevo Therapeutics APVO Q1 2026 earnings
Reported May 13, 2026 · After market close
EPS-$6.41Miss by $0.81
EPS estimate-$5.60
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$3.72
Versus estimates
Diluted EPS
FAQ
- When did Aptevo Therapeutics report Q1 2026 earnings?
- Aptevo Therapeutics (APVO) reported Q1 2026 earnings on May 13, 2026 after market close.
- What were Aptevo Therapeutics's Q1 2026 revenue and EPS?
- Aptevo Therapeutics reported eps of $-6.41 for Q1 2026.
- Did Aptevo Therapeutics beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-5.60 by $0.81.
- How did Aptevo Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 99.6% from $-1579.14.
- Where can I find Aptevo Therapeutics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-221593) and the 10-Q periodic report (0001193125-26-221661) directly on SEC EDGAR. The filing index links above go to sec.gov.
